Company / Operating Income per Share
PALVELLA THERAPEUTICS, INC. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$6.33
FY2024
5-year range
-$6.33 / -$0.16
FY2020-FY2024
Trend
-3875.6%
vs FY2023
Sector context
#180 of 201
Health Care
What the data says
Operating Income per Share changed -3876% YoY in FY2024, a notable deviation from the 9-year average annual change of -421%.
Based on SEC 10-K filings.
-6.33 in FY2024.
Declined from $-0.60 to $-6.33 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 201This company -$6.33 Sector average -$3.23
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2024, operating income per share decreased 3875.6% year-over-year.
- Ranks #180 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$6.33 | -3875.6% |
| FY2023 | -$0.16 | +73.5% |
| FY2022 | -$0.60 | +0.6% |
| FY2021 | -$0.61 | -23.1% |
| FY2020 | -$0.49 | +1.9% |
| FY2019 | -$0.50 | -54.7% |
| FY2018 | -$0.32 | +38.7% |
| FY2017 | -$0.53 | +7.5% |
| FY2016 | -$0.57 | +42.1% |
| FY2015 | -$0.99 | -62.2% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026